Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease
Antioxidant effect of zinc picolinate in patients with chronic obstructive pulmonary disease
复制标题
DOI:
10.1016/j.rmed.2008.01.010
复制
发表时间:
2008-06-01
影响因子:
4.3
通讯作者:
Kucuk, Omer
中科院分区:
文献类型:
--
作者:
Kirkil, Gamze;Muz, Mehmet Hamdi;Kucuk, Omer
An imbalance between oxidative stress and antioxidant capacity is thought to play an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). However, studies in regard to stable COPD patients and effect of zinc supplementation are lacking. We investigated the effects of zinc picolinate supplementation on the oxidant stress, and pulmonary function tests (PFTs) of patients with stable COPD. Thirty patients with COPD, and 15 healthy non-smokers who were matched for age and sex were included in the study. Their baseline spirometry, plasma malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and zinc levels were measured. All parameters were repeated after 8 weeks of supplementation with 22 mg of zinc picolinate daily. The mean MDA levels in the COPD group at baseline were higher than controls (0.51 +/- 0.15 vs 0.39 +/- 0.15 nmol/mL, p = 0.037), while SOD (0.16 +/- 0.022 vs 0.20 +/- 0.04 U/mL, p = 0.000), CAT (14.79 +/- 3.03 vs 17.37 +/- 2.60 k/mL, p=0.008) and zinc levels (77.33 +/- 4.29 vs 91.45 +/- 3.95 mg/dL, p = 0.000) were lower in the patients compared to controls. Eight weeks of zinc supplementation produced significant increase in mean SOD (p = 0.029) and zinc levels (p